You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Receptor Occupancy

Showing 1 - 25 of 7,369
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Bipolar Depression Trial in New York (Cariprazine)

Not yet recruiting
  • Bipolar Depression
  • New York, New York
    Columbia University Medical Center
Jan 23, 2023

Alzheimer Trial in New Haven (BMS-984923)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Yale University
Oct 4, 2022

Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Palo Alto, California
    Stanford Medical Center
Nov 15, 2022

D3 Dopamine Receptor, Cocaine-dependent, Healthy Volunteer Trial in Philadelphia ([18F]FTP PET/CT)

Active, not recruiting
  • D3 Dopamine Receptor
  • +2 more
  • [18F]FTP PET/CT
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 5, 2022

Cognitive Disorders Trial in Leuven (SDI-118, Placebo)

Completed
  • Cognitive Disorders
  • Leuven, Belgium
    Centre for Clinical Pharmacology, UZ Leuven
Aug 2, 2022

Schizophrenia Trial in Saint Louis (LB-102)

Completed
  • Schizophrenia
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 28, 2022

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

MDD Trial in London (MIJ821)

Not yet recruiting
  • Major Depressive Disorder
  • London, United Kingdom
    Parexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022

Healthy Volunteers Trial in Creve Coeur, Saint Louis (ITI-333)

Not yet recruiting
  • Healthy Volunteers
  • Creve Coeur, Missouri
  • +1 more
Jul 20, 2022

Multiple Sclerosis Trial in London (PIPE-307)

Completed
  • Multiple Sclerosis
  • London, United Kingdom
    Hammersmith Medicines Research
Oct 4, 2022

Healthy Trial in New Haven (LY3857210)

Recruiting
  • Healthy
  • New Haven, Connecticut
    Invicro, Institute for Neurodegenerative Disorders
Sep 27, 2022

Type 2 Diabetes Trial in Uppsala (SAR425899, [68Ga] Ga-DO3A-VS-Cys40-Tuna-2 (glucagon receptor tracer), [68Ga]

Completed
  • Type 2 Diabetes Mellitus
  • Uppsala, Sweden
    Investigational Site Number 7520001
Apr 21, 2022

Health Volunteers, Huntington Disease Trial in Leipzig (pridopidine (90 mg))

Completed
Has Results
  • Health Volunteers, Huntington Disease
  • pridopidine (90 mg)
  • Leipzig, Germany
    Teva Investigational Site 32648
Nov 18, 2021

Healthy Volunteers Trial in Stockholm (AZD2115, SPIRIVA, [11C]AZ13754366)

Completed
  • Healthy Volunteers
  • Stockholm, Sweden
    Research Site
Aug 27, 2021

Healthy Trial in Harrow (HTL0014242)

Completed
  • Healthy
  • Harrow, Middlesex, United Kingdom
    Parexel Early Phase Clinical Unit
Jul 6, 2021

Healthy Subjects Trial in Tokyo (TS-091)

Completed
  • Healthy Subjects
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Nov 12, 2020

Healthy, Parkinson Disease Trial in Stockholm (foliglurax)

Terminated
  • Healthy
  • Parkinson Disease
  • Stockholm, Sweden
    Karolinska Institutet
Dec 8, 2020

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

Recruiting
  • Neurodegenerative Diseases
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 24, 2023

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (risperidone)

Unknown status
  • Schizophrenia
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 6, 2020

Melanoma Trial in Rotterdam (Nivolumab)

Recruiting
  • Melanoma
  • Rotterdam, Pending, Netherlands
    Erasmus MC
Oct 30, 2023

Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
    New Haven, Connecticut
Jan 18, 2023

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)

Completed
  • Schizophrenia
  • +4 more
  • Risperidone/Olanzapine and PET scans
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Jun 2, 2022

Healthy Trial in Leuven (JNJ-64140284, Fluorine-18 Labeled [18F]-JNJ-64511070)

Terminated
  • Healthy
  • Leuven, Belgium
    UZ Leuven Gasthuisberg
Dec 17, 2019